|
06-151-2
|
|
Circulating markers that underlie the transition from compensated hypertrophy to heart failure
|
|
Dr. Bruce Liang
|
|
Early detection and prevention are key features in treating subjects with heart failure. We are looking to see of caspase-3 and dystrophin can be detected in human circulation. If so, we will determine whether they are predictors for the transition between compensated and de-compensated heart failure.
|
Cardiovascular (Heart, High Blood Pressure, Etc.)
|
|
|
18 Years and older. Imaging evidence of heart failure (cardiomegaly, poor contractile function or echocardiographic Doppler evidence of diastolic dysfunction or elevated right- or left-sided filling pressures)
|
|
Sharon Dimauro. Telephone: (860) 679-2692. Email: dimauro@uchc.edu
|
|
Enrolling/recruiting. For current recruitment status, please check with study contact.
|
|
clinicaltrials.gov/ct2/show/NCT00762008?term=%22Connecticut+Health+Center%22&rank=5
|